Roche (RHHBY) expects an increase in Group sales in the mid single digit range. Core earnings per share are targeted to develop in the high single to low double digit range. Roche expects to further increase its dividend in Swiss francs.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Trump Trade: Trump administration prepares new probe into pharma prices
- Trump admin prepares new probe into U.S. pharma prices, FT says
- Celcuity price target raised to $95 from $70 at Needham
- Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’
- Genentech announces FDA approval for Gazyva for active lupus nephritis